Status:
COMPLETED
Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients.
Lead Sponsor:
Institut de Cancérologie de Lorraine
Conditions:
Gynecologic Cancer
Symptoms and Signs
Eligibility:
FEMALE
65+ years
Brief Summary
Systematic screening for cervical cancer stops in France at 65 years old. The incidence of certain types of gynecological neoplasia increases with age (endometrium, vulva). Diagnosis delay of 8 months...
Detailed Description
Our study assess the reasons for which the patient took time to go to the doctor despite of their symptoms. We use a qualitative methodology. Our study categorizes lived experiences, recorded in semis...
Eligibility Criteria
Inclusion
- Women of 65 years or more treated or followed at Lorraine Institute of Oncology
- Diagnosed after 65 years or later of a low gynecological cancer
- Without diagnosis of dementia
- Retained ability to express by herself without assistance
- Affiliated to public health system
- Informed and having expressed her non-opposition
Exclusion
- Women under 65 or diagnosed before being 65 of a low gynecological cancer
- Diagnosed of dementia
- No longer to express herself
- Patient deprived of freedom
Key Trial Info
Start Date :
October 30 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 27 2018
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03336177
Start Date
October 30 2017
End Date
July 27 2018
Last Update
August 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancérologie de Lorraine (ICL)
Vandœuvre-lès-Nancy, France